Method For Ameliorating Pain By Modification Of Nmda Receptors Through Inhibition Of Src

Abstract

The present invention provides a method for ameliorating inflammatory and/or neuropathic pain in a subject by modifying the activity of N-methyl-D-aspartate (NMDA) receptors in cells of the subject by inhibition of the interaction of the unique domain of the tyrosine kinase Src enzyme and the NMDA receptor complex.


Claims
Owners (US)

Information currently unavailable.

Download PDF
Document Preview
Document History
  • Publication: Apr 17, 2012
  • Application: Jun 21, 2011
    US US 201113165764 A
  • Priority: Jun 21, 2011
    US US 201113165764 A
  • Priority: Aug 29, 2006
    US US 51280206 A
  • Priority: Mar 30, 2004
    US US 81410904 A

Download Citation


Sign in to the Lens

Feedback